Clinical Trial Update: Almorexant in Primary Insomnia [Phase 1]

View source ↗

Summary

Phase 1 trial update for Almorexant in primary insomnia indicates the study completed, with no efficacy or safety results reported in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Almorexant (Almorexant)

Snippet

Sponsor: Midnight Pharma, LLC | Conditions: Insomnia, Primary Insomnia | Phase 1 | Status: COMPLETED